94 related articles for article (PubMed ID: 9276622)
1. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
Lear JT; Smith AG; Heagerty AH; Bowers B; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
Carcinogenesis; 1997 Aug; 18(8):1499-503. PubMed ID: 9276622
[TBL] [Abstract][Full Text] [Related]
2. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual.
Lear JT; Heagerty AH; Smith A; Bowers B; Payne CR; Smith CA; Jones PW; Gilford J; Yengi L; Alldersea J; Fryer AA; Strange RC
Carcinogenesis; 1996 Sep; 17(9):1891-6. PubMed ID: 8824510
[TBL] [Abstract][Full Text] [Related]
3. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.
Lear JT; Smith AG; Bowers B; Heagearty AH; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
J Invest Dermatol; 1997 Apr; 108(4):519-22. PubMed ID: 9077484
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
[TBL] [Abstract][Full Text] [Related]
5. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
Yengi L; Inskip A; Gilford J; Alldersea J; Bailey L; Smith A; Lear JT; Heagerty AH; Bowers B; Hand P; Hayes JD; Jones PW; Strange RC; Fryer AA
Cancer Res; 1996 May; 56(9):1974-7. PubMed ID: 8616834
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Hartland AJ; Whiteside JR; Jones PW; Strange RC
Pharmacogenetics; 2001 Apr; 11(3):247-54. PubMed ID: 11337940
[TBL] [Abstract][Full Text] [Related]
9. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
[TBL] [Abstract][Full Text] [Related]
10. Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.
R Yang X; Pfeiffer RM; Goldstein AM
J Med Genet; 2006 Apr; 43(4):e16. PubMed ID: 16582078
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.
Ramachandran S; Hoban PR; Ichii-Jones F; Pleasants L; Ali-Osman F; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Pharmacogenetics; 2000 Aug; 10(6):545-56. PubMed ID: 10975609
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system.
Ramachandran S; Fryer AA; Lovatt TJ; Smith AG; Lear JT; Jones PW; Strange RC
Cancer Lett; 2003 Jan; 189(2):175-81. PubMed ID: 12490310
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6.
Worrall SF; Corrigan M; High A; Starr D; Matthias C; Wolf CR; Jones PW; Hand P; Gilford J; Farrell WE; Hoban P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Oct; 8(5):433-9. PubMed ID: 9825835
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children.
Aplenc R
Pediatr Blood Cancer; 2004 Oct; 43(5):539-41. PubMed ID: 15382269
[No Abstract] [Full Text] [Related]
18. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
Ramsay HM; Harden PN; Reece S; Smith AG; Jones PW; Strange RC; Fryer AA
J Invest Dermatol; 2001 Aug; 117(2):251-5. PubMed ID: 11511301
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in glutathione S-transferase loci as a risk factor for common cancers.
Strange RC; Lear JT; Fryer AA
Arch Toxicol Suppl; 1998; 20():419-28. PubMed ID: 9442313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
